Choroideremia: The Endpoint Endgame.
Abdalla Elsayed MEA, Taylor LJ, Josan AS, Fischer MD, MacLaren RE.
Int J Mol Sci. 2023 Sep 20;24(18):14354. doi: 10.3390/ijms241814354.
Choroideremia: molecular mechanisms and therapies.
Sarkar H, Moosajee M.
Trends Mol Med. 2022 May;28(5):378-387. doi: 10.1016/j.molmed.2022.02.011. Epub 2022 Mar 24.
Choroideremia.
Dimopoulos IS, Radziwon A, St Laurent CD, MacDonald IM.
Curr Opin Ophthalmol. 2017 Sep;28(5):410-415. doi: 10.1097/ICU.0000000000000392.
CHOROIDEREMIA: Retinal Degeneration With an Unmet Need.
Pennesi ME, Birch DG, Duncan JL, Bennett J, Girach A.
Retina. 2019 Nov;39(11):2059-2069. doi: 10.1097/IAE.0000000000002553.
Molecular Therapies for Choroideremia.
Cehajic Kapetanovic J, Barnard AR, MacLaren RE.
Genes (Basel). 2019 Sep 23;10(10):738. doi: 10.3390/genes10100738.
X-Linked Choroideremia.
Zhou A, Tsang SH, Sharma T, Diaconita V.
Adv Exp Med Biol. 2025;1467:43-49. doi: 10.1007/978-3-031-72230-1_9.
Multimodal Imaging in Choroideremia.
Foote KG, Roorda A, Duncan JL.
Adv Exp Med Biol. 2019;1185:139-143. doi: 10.1007/978-3-030-27378-1_23.
X-linked Choroideremia.
Tsang SH, Sharma T.
Adv Exp Med Biol. 2018;1085:37-42. doi: 10.1007/978-3-319-95046-4_9.
Choroideremia Gene Therapy.
Lam BL, Davis JL, Gregori NZ.
Int Ophthalmol Clin. 2021 Oct 1;61(4):185-193. doi: 10.1097/IIO.0000000000000385.
Choroideremia: molecular mechanisms and development of AAV gene therapy.
Patrício MI, Barnard AR, Xue K, MacLaren RE.
Expert Opin Biol Ther. 2018 Jul;18(7):807-820. doi: 10.1080/14712598.2018.1484448. Epub 2018 Jun 22.
